Javascript must be enabled to continue!
Legumain (EC 3.4.22.34)
View through CrossRef
Abstract
It has been known since the initial discovery of Csoma and Polgar in 1984 [1292] that the seeds of several legumes and other plants contain an endopeptidase specific for the hydrolysis of asparaginyl bonds. The enzyme has been termed asparagi!!JI endopeptidase [1259] and vacuolar processing enzyme [1305], but the name recommended by the nomenclature committee of the IUBMB is legumain. Kembhavi et al. [1389] in 1993 isolated legumain from moth bean (Vigna aconitifo!ia) and described a convenient fluorimetric assay in which the substrate was Z-Ala-Ala-Asn-NHMec. The cloning and sequencing of legumain from castor bean [1381] revealed some sequence identities with the 'haemoglobinase', from the blood fluke, Schistosoma mansoni. The parasite enzyme has now been shown also to be an asparaginyl endopeptidase and termed Schistosoma legumain [1638]. In reviewing the cysteine peptidases, Rawlings and Barrett [1187] assigned the number Cl 3 to the peptidase family containing the legume asparaginyl endopeptidase and the Schistosoma endopeptidase. This family shows no relationship to the papain family, Cl, to which all the other lysosomal cysteine proteinases belong. During 1995, the publication of human EST sequences made it clear that the human genome contains a form of legumain. This prompted Barrett and co-workers in 1997 [1783] to clone and sequence the cDNA for human legumain and to isolate and characterize the enzyme from pig kidney, using the assay that they had introduced earlier for the moth bean enzyme. The properties of the mammalian enzyme were so similar to those of the plant and Schistosoma forms that it seems appropriate to retain the same name, leJ,umain, for the mammalian enzyme.
Oxford University PressOxford
Title: Legumain (EC 3.4.22.34)
Description:
Abstract
It has been known since the initial discovery of Csoma and Polgar in 1984 [1292] that the seeds of several legumes and other plants contain an endopeptidase specific for the hydrolysis of asparaginyl bonds.
The enzyme has been termed asparagi!!JI endopeptidase [1259] and vacuolar processing enzyme [1305], but the name recommended by the nomenclature committee of the IUBMB is legumain.
Kembhavi et al.
[1389] in 1993 isolated legumain from moth bean (Vigna aconitifo!ia) and described a convenient fluorimetric assay in which the substrate was Z-Ala-Ala-Asn-NHMec.
The cloning and sequencing of legumain from castor bean [1381] revealed some sequence identities with the 'haemoglobinase', from the blood fluke, Schistosoma mansoni.
The parasite enzyme has now been shown also to be an asparaginyl endopeptidase and termed Schistosoma legumain [1638].
In reviewing the cysteine peptidases, Rawlings and Barrett [1187] assigned the number Cl 3 to the peptidase family containing the legume asparaginyl endopeptidase and the Schistosoma endopeptidase.
This family shows no relationship to the papain family, Cl, to which all the other lysosomal cysteine proteinases belong.
During 1995, the publication of human EST sequences made it clear that the human genome contains a form of legumain.
This prompted Barrett and co-workers in 1997 [1783] to clone and sequence the cDNA for human legumain and to isolate and characterize the enzyme from pig kidney, using the assay that they had introduced earlier for the moth bean enzyme.
The properties of the mammalian enzyme were so similar to those of the plant and Schistosoma forms that it seems appropriate to retain the same name, leJ,umain, for the mammalian enzyme.
Related Results
Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis
Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis
AbstractSince reports on the clinical significance of legumain in cancer have shown inconsistent results, we systematically evaluated clinical indicators of legumain in cancer. We ...
FAIMS-enabled N-terminomics analysis reveals novel legumain substrates in murine spleen
FAIMS-enabled N-terminomics analysis reveals novel legumain substrates in murine spleen
Abstract
Aberrant levels of the asparaginyl endopeptidase legumain have been linked to inflammation, neurodegeneration and cancer, yet our unders...
Legumain-Specific Near-Infrared Fluorescence “Turn
On” for Tumor-Targeted Imaging
Legumain-Specific Near-Infrared Fluorescence “Turn
On” for Tumor-Targeted Imaging
Abstract
Legumain is one of the cysteine proteases which can serve as an essential indicator for cancer diagnosis. Near-infrared (NIR) nanoprobes with fluorescenc...
OnBlastocystissecreted cysteine proteases: a legumain-activated cathepsin B increases paracellular permeability of intestinal Caco-2 cell monolayers
OnBlastocystissecreted cysteine proteases: a legumain-activated cathepsin B increases paracellular permeability of intestinal Caco-2 cell monolayers
SUMMARYBlastocystisspp. pathogenic potential remains unclear as these anaerobic parasitic protozoa are frequently isolated from stools of both symptomatic and asymptomatic subjects...
Autocatalytic activation of human legumain at aspartic acid residues
Autocatalytic activation of human legumain at aspartic acid residues
Human legumain was characterized following overexpression in a murine cell line as the C‐terminal Ig‐fusion protein. Upon acid treatment, the prolegumain autoproteolyzed distal to ...
Role of LGMN in tumor development and its progression and connection with the tumor microenvironment
Role of LGMN in tumor development and its progression and connection with the tumor microenvironment
Legumain (LGMN) has been demonstrated to be overexpressed not just in breast, prostatic, and liver tumor cells, but also in the macrophages that compose the tumor microenvironment....
Abstract 2489: Glycoproteomic analysis of breast cancer cell lines for biomarker discovery
Abstract 2489: Glycoproteomic analysis of breast cancer cell lines for biomarker discovery
Abstract
Glycosylation is one of the most ubiquitous protein post-translational modifications observed in eukaryotic organisms. In cancer, key cellular pathways and ...
Protease-sensitive Linkers
Protease-sensitive Linkers
The development and maturation of protease-cleavable linkers as an efficient and flexible linker strategy, compatible with a variety of payload classes, is described. Lysosomal pro...

